It has been shown to have direct MMAE-mediated cytotoxic effects on CLDN18.2-overexpressing tumor cells, as well as ADCC and CDC action and bystander-killing effects on surrounding tumor cells in preclinical studies [64,65,66]. The gene discussed is CLDN18; the disease is neoplasm.